Literature DB >> 8315010

Direct fluorescent-antibody confirmation of chlamydial antigen below the detection threshold of the chlamydiazyme enzyme-linked immunosorbent assay.

J A Kellogg1, J W Seiple, E S Stroll.   

Abstract

Of 4,000 endocervical specimens tested with the Chlamydiazyme enzyme-linked immunosorbent assay (Abbott Laboratories), 233 (5.8%) gave positive results (A492 above the cutoff), which were confirmed with a blocking reagent (Abbott). An additional 34 specimens (14.6%) with chlamydial antigen were detected and confirmed with the direct fluorescent-antibody test (Syva) from among those 66 Chlamydiazyme-negative specimens which had A492s that ranged from 0.030 to the cutoff and that could be blocked by > or = 50% with the blocking reagent.

Mesh:

Substances:

Year:  1993        PMID: 8315010      PMCID: PMC265598          DOI: 10.1128/jcm.31.6.1646-1647.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women.

Authors:  J R Schwebke; W E Stamm; H H Handsfield
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

Review 2.  Clinical and laboratory considerations of culture vs antigen assays for detection of Chlamydia trachomatis from genital specimens.

Authors:  J A Kellogg
Journal:  Arch Pathol Lab Med       Date:  1989-05       Impact factor: 5.534

3.  Impact of endocervical specimen quality on apparent prevalence of Chlamydia trachomatis infections diagnosed using an enzyme-linked immunosorbent assay method.

Authors:  J A Kellogg; J W Seiple; J L Klinedinst; J S Levisky
Journal:  Arch Pathol Lab Med       Date:  1991-12       Impact factor: 5.534

4.  Effect of endocervical specimen quality on detection of Chlamydia trachomatis and on the incidence of false-positive results with the Chlamydiazyme method.

Authors:  J A Kellogg; J W Seiple; C L Murray; J S Levisky
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis.

Authors:  J Moncada; J Schachter; M Shipp; G Bolan; J Wilber
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

6.  Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix.

Authors:  J Moncada; J Schachter; G Bolan; J Engelman; L Howard; I Mushahwar; G Ridgway; G Mumtaz; W Stamm; A Clark
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

7.  Use of a direct fluorescent antibody test for detecting Chlamydia trachomatis cervical infection in women seeking routine gynecologic care.

Authors:  R S Phillips; P A Hanff; R S Kauffman; M D Aronson
Journal:  J Infect Dis       Date:  1987-10       Impact factor: 5.226

Review 8.  Diagnosis of Chlamydia trachomatis genitourinary infections.

Authors:  W E Stamm
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

  8 in total
  7 in total

1.  Lowering the cut off value of an automated chlamydia enzyme immunoassay and confirmation by PCR and direct immunofluorescent antibody test.

Authors:  C Y Tong; C Donnelly; N Hood
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

2.  A 1-year evaluation of Syva MicroTrak Chlamydia enzyme immunoassay with selective confirmation by direct fluorescent-antibody assay in a high-volume laboratory.

Authors:  E L Chan; K Brandt; G B Horsman
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

3.  Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection.

Authors:  D Dean; D Ferrero; M McCarthy
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 4.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  C M Black
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  Laboratory methods for detection of Chlamydia trachomatis: survey of laboratories in Washington State.

Authors:  K L Suchland; J M Counts; W E Stamm
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

6.  Evaluation of Sanofi Diagnostics Pasteur Chlamydia Microplate EIA shortened assay and comparison with cell culture and Syva Chlamydia MicroTrak II EIA in high- and low-risk populations.

Authors:  E L Chan; K Brandt; G Horsman
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

7.  PCR and direct fluorescent-antibody staining confirm Chlamydia trachomatis antigens in swabs and urine below the detection threshold of Chlamydiazyme enzyme immunoassay.

Authors:  J Krepel; I Laur; A Sproston; K Luinstra; D Jang; J Mahony; M Chernesky
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.